Showing results (2731-2740 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|May 19, 2009
Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover studyJaret Malloy, Edmund Capparelli, Michael Gottschalk, et al.Clinical Therapeutics|May 19, 2009
An oral sulfonylurea in the treatment of transient neonatal diabetes mellitusLindsey A Loomba-Albrecht, Nicole S Glaser, Dennis M Styne, et al.Clinical Therapeutics|May 19, 2009
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemiaSonja V Sorensen, Kevin D Frick, Alexander Wade, et al.Clinical Therapeutics|May 19, 2009
The financial implications for Medicare of greater use of peritoneal dialysisNancy Neil, Steven Guest, Leslie Wong, et al.Clinical Therapeutics|October 9, 2008
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorderSofie A M K Houthoofd, Manuel Morrens, Bernard G C SabbeClinical Therapeutics|October 9, 2008
Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label studySanjay J Mathew, Amir Garakani, John F Reinhard, et al.Clinical Therapeutics|October 9, 2008
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in TaiwanLi-Jen Lin, Ming-Hui Cheng, Cheng-Han Lee, et al.Clinical Therapeutics|September 23, 2008
Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of RamadanAbdallah Kobeissy, Mira S Zantout, Sami T AzarClinical Therapeutics|September 23, 2008
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinasesPatrick J Medina, Susan GoodinClinical Therapeutics|September 23, 2008
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trialSaul ShiffmanPageof 678